Biobase Sweden AB closes second capitalization round at new evaluation of 25 million SEK

We are happy to announce that Biobase Sweden AB closes the second of three planned capitalization rounds of 4 million SEK at current evaluation of 25 million SEK pre-money.
The round was oversubscribed.

(For more information download press release)

 

 

Facebook
Twitter
LinkedIn
Pinterest